Liraglutide (Saxenda)
An established daily GLP-1 receptor agonist for weight management, producing moderate but consistent weight loss results.
Overview
Liraglutide (Saxenda) was the first GLP-1 receptor agonist approved specifically for chronic weight management. While producing less dramatic results than newer options, it has a longer track record and extensive safety data. It requires daily injections but remains an effective option for medical weight loss.
How It Works
Liraglutide activates GLP-1 receptors in the brain to increase satiety and reduce hunger. It slows gastric emptying and modulates the reward-related aspects of eating. These combined effects lead to reduced caloric intake and sustained weight loss.
Benefits
Potential Side Effects
Dosage Information
Started at 0.6mg daily, increased weekly by 0.6mg to the target dose of 3.0mg daily. Dose escalation typically takes 5 weeks.
Administration
Subcutaneous injection (daily)
Rating
4.2 / 5.0
Category
Weight Loss Hormones
Common Symptoms
JoinFridays
Starting at $117/month
Shed
10% off first month
TrimRx
Starting at $147/month
Common Questions
Find a Provider for Liraglutide (Saxenda)
Compare top providers offering this treatment.
Compare Providers